Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01785238
Other study ID # RC12_0238
Secondary ID
Status Completed
Phase N/A
First received January 18, 2013
Last updated October 15, 2014
Start date February 2013
Est. completion date October 2013

Study information

Verified date October 2014
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority France:ANSM
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the signs of nephronic reduction in preterm infants who have presented neonatal acute renal failure. The investigators hypothesize that signs of nephronic reduction would appear earlier in former preterm with neonatal acute renal failure than in control preterm infants.


Description:

50 former preterm infants who presented acute renal failure will be evaluated between 3 to 10 years.

They will be compared to 25 control former preterm infants without renal dysfunction for signs of nephronic reduction.

At inclusion, in order to analyse renal function, all infants will have blood sampling, renal echography and blood pressure measurement. Urine sample will also be collected.

Two months later, parents will be informed on the results.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date October 2013
Est. primary completion date October 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 3 Years to 10 Years
Eligibility Inclusion Criteria:

- For both group of cases (50 infants having presented acute renal failure in preterm) AND group of control cases (25 infants without this) :former preterm infant born before 33 weeks of gestational age between january 2003 and june 2010 and hospitalized in the neonatal intensive care unit of Nantes University Hospital.

- Specific to cases: neonatal acute renal failure: serum creatinine>130 micromol/l from the third day of life.

- Control cases: no such renal dysfunction

Exclusion Criteria:

- no parental consent

- other causes of renal failure: congenital uropathy, congenital nephropathy

- congenital cardiopathy, polymalformative syndrome

Study Design

Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Other:
renal echography
renal echography to analyse the kidney
Blood sampling
Blood sampling to analyse different parameters of renal function
collection of an urine sample
Collection of an urine sample to perform analysis of renal function parameters
Blood pressure measurement


Locations

Country Name City State
France CHU of Nantes Nantes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary microalbuminuria The primary outcome of this study is to prove that former preterm infants with neonatal acute renal failure are at higher risk of nephronic reduction than control former preterm infants and that they will present microalbuminuria as earlier sign of nephronic reduction. Precisely, if microalbuminuria divided by creatinuria is above 20mg/g or 2mg/mmol, it will be considered as pathologic. Day 1 (at inclusion) No
Secondary measurement of blood pressure Evaluation of other renal parameters: blood pressure, renal filtration, tubular functions evaluation of renal size and differentiation by ultrasound Day 1 (at inclusion) No
Secondary measurement of length and volume of kidney by renal echography day 1 No
Secondary creatinine clearance day 1 No
Secondary calciuria Day 1 No
Secondary sodium clearance day 1 No